ABCL Latest Press Releases

-- December 8, 2025 --

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Business Wire 4:05 PM

-- November 10, 2025 --

AbCellera Appoints Dr. Stephen Quake to its Board of Directors Business Wire 9:00 AM

-- November 6, 2025 --

AbCellera Reports Q3 2025 Business Results Business Wire 4:05 PM

-- October 7, 2025 --

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 Business Wire 4:05 PM

-- September 29, 2025 --

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025 Business Wire 4:05 PM

-- September 10, 2025 --

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer Business Wire 9:07 AM

-- August 27, 2025 --

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575 Business Wire 9:00 AM

-- August 12, 2025 --

AbCellera to Participate at Upcoming Investor Conferences in September Business Wire 4:05 PM

-- August 7, 2025 --

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Business Wire 4:22 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software